RepliCel Life Sciences Inc (OTCQB:REPCF)

0.2784
Delayed Data
As of Jun 22
 +0.0213 / +8.29%
Today’s Change
0.25
Today|||52-Week Range
0.55
-10.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash462.0K126.6K45.3K396.7K
 
 
 
 
 
Short Term Investment Cash-1.3M-280.9K-86.8K336.2K
 
 
 
 
 
Cash & Short Term Investments1.8M126.6K1.1M396.7K
 
 
 
 
 
 
ReceivablesReceivables25.1K18.6K49.3K38.7K
 
 
 
 
 
 
InventoriesInventories--0.000.000.00--
 
Current AssetsOther Current Assets44.2K139.1K176.0K230.8K
 
 
 
 
 
Current Assets1.8M284.2K1.4M666.3K
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross46.5K40.3K41.8K44.7K
 
 
 
 
 
Depreciation-24.1K-25.1K-30.3K-35.8K
 
 
 
 
 
Other Assets0.000.000.000.00--
Total Assets1.8M299.4K1.4M675.2K
 
 
 
 
 
 
LiabilitiesAccrued Expenses--629.8K278.9K683.4K
 
 
 
 
Other Current Liabilities289.3K732.6K463.6K930.6K
 
 
 
 
 
Other Liabilities289.3K732.6K463.6K930.6K
 
 
 
 
 
 
Total LiabilitiesTotal Liabilities289.3K732.6K463.6K930.6K
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity1.6M-433.2K899.6K-255.4K
 
 
 
 
 
Total Shareholder Equity1.6M-433.2K899.6K-255.4K
 
 
 
 
 
 
Share InformationCommon Shares Outstanding5.5M6.3M15.7M21.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.